Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GE Healthcare and BAC, a provider of antibody-based affinity purification technology, have launched new bioprocess affinity resin, LambdaFabSelect.
Subscribe to our email newsletter
The new resin is a designed tool for the GMP-regulated purification of antibodies and antibody fragments that contain a lambda light chain.
GE Healthcare Life Sciences custom design media director Henrik Ihre said collaborating with the team at BAC has resulted in a ready-to-use product for all human antibody formats containing a lambda light chain.
BAC CEO Laurens Sierkstra said LambdaFabSelect enables bioprocess engineers to use BAC’s ligand technology to produce Fab fragments with a lambda light chain for clinical and commercial use.
"It provides greater flexibility in the purification of these important biotherapeutics," added Sierkstra.